Abstract
Cytodifferentiation in many melanocytic cells is regulated through the adenylate cyclase-cAMP pathway. To analyse the molecular changes associated with this process we have compared the proteins produced by two closely related cell lines which, though derived from a single cell line, respond very differently to modulation of this signalling pathway. The human melanoma cell line DX3 shows little change inin vitro characteristics following treatment with cAMP elevating agents; in contrast the more malignant DX3 LT5.1 variant, derived from the DX3 parental line, shows pronounced dendrification, decreased proliferation and a reduction in metastatic capacity after similar treatment. The two cell lines were treated with phosphodiesterase inhibitors for 5 days and then processed for two-dimensional gel characterization using an immobilized pH gradient for the IEF dimension. Proteins were detected by silver staining the gels and protein intensities were digitized using a laser densitometer. Two-dimensional gel patterns were edited, matched and a melanoma protein database of 637 spots constructed using PDQUEST software on an Orion 1/05 computer. Eleven proteins were lost and four new proteins were detected in both cell lines following treatment. Twenty-two proteins were present in DX3 LT5.1 after treatment but not in untreated lines or treated DX3. These differentially expressed proteins may be associated with the observed changes in differentiation patterns and metastasis. Our results illustrate the resolving power of this technique and suggest potential applications to the study of cellular differentiation.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Abdel-Malek, Z. A., Swope, V. B., Amornsiripanitch, N., andNordlund, J. J., 1987,In vitro modulation of proliferation and melanization of S91 melanoma cells by prostaglandin.Cancer Research,47, 3141–3146.
Albino, A. P., Nanus, D. M., Mentle, I. R., Cordon-Cardo, C., McNutt, N. S., Bressler, J., andAndreeff, M., 1989, Analysis ofras oncogenes in malignant melanoma and precursor lesions: correlation of point mutations with differentiation phenotype.Oncogene,4, 1363–1374.
Altevogt, P., andSchirrmacher, V., 1984, New plasma membrane proteins expressed by a high metastatic variant of a chemically induced tumor.European Journal of Cancer and Clinical Oncology,20, 1155–1162.
Bradford, M. M., 1976, A rapid and sensitive method for the quantitation of microgram quantities of protein utilising the principle of protein-dye binding.Analytical Biochemistry,72, 248–254.
Brown, R., Marshall, C. J., Pennie, S. B., andHall, A., 1984, Mechanism of activation of anN-ras gene in the human fibrosarcoma line HT-1080.EMBO Journal,3, 1321–1326.
Dean, D. C., Blakeley, M. S., Newby, R. F., Ghaal, P., Henninghausen, L., andBourgeois, S., 1989, Forskolin inducibility and tissue-specific expression of the fibronectin promoter.Molecular and Cellular Biology,9, 1498–1506.
Dipasqale, A., andMcQuire, J., 1977, Dibutyl cyclic AMP arrests the growth of cultivated Cloudsman melanoma cells in the S and G2 phases of the cell cycle.Journal of Cellular Physiology,93, 395–406.
Domscheit, A.,Postel, W.,Jakschies, D.,Wussow, P., andGorg, A., 1989, Two-dimensional electrophoresis of melamona cell proteins.Methodical Aspects. Electrophoresis Forum 1989, edited by B. J. Radola, pp. 23–28.
Dunn, M. J., 1987, Two dimensional polyacrylamide gel electrophoresis.Advances in Electrophoresis,1, 1–109.
Dunn, M. J.,Patel, K.,Seymour, C.,Yacoub, M. M.,Easty, D.,Domscheit, A.,Günther, S.,Postel, W., andGorg, A., 1989, Computer analysis of human melanocyte proteins separated by two-dimensional polyacrylamide gel electrophoresis using immobilised pH gradients in the first dimension.Electrophoresis Forum 1989, edited by B. J. Radola, pp. 14–22.
Eisenger, M., andMarko, O., 1982, Selective proliferation of normal human melanocytesin vitro in the presence of phorbol ester and cholera toxin.Proceedings of the National Academy of Sciences, U.S.A.,79, 2018–2022.
Giuffre, L., Isler, P., Schreyer, M., andCarrel, S., 1988, Melanoma-associated differentiation antigens: investigation with monoclonal antibodies.European Journal of Cancer and Clinical Oncology,24, Suppl. 2, 551–558.
Gorg, A., Postel, W., andGunther, S., 1988, The current state of two dimensional electrophoresis with immobilised pH gradients.Electrophoresis,9, 531–546.
Gorg, A., Postel, W., Domscheit, A., andGunther, S., 1988, Two dimensional electrophoresis with immobilised pH gradients of leaf protein from barley: method, reproducibility and genetic aspects.Electrophoresis,9, 681–692.
Greig, R. G., Caltabiano, L., Reid, R., Feld, J., andPoste, G., 1983, Heterogeneity of protein phosphorylation in metastatic variants of B16 melanoma.Cancer Research,43, 6057–6065.
Herlyn, M., Clark, W. H., Rodeck, U., Mancianti, M. L., Jambrosia, J., andKoprowski, H., 1987, Biology of disease, biology of tumor progression in human melanocytes.Laboratory Investigation,56, 461–474.
Herlyn, M., andKoprowski, H., 1988, Melanoma antigens: immunological and biological characterisation and clinical significance.Annual Review of Immunology,6, 283–308.
Houghton, A. N., Eisinger, M., Albino, A. P., Cairncross, J. G., andOld, L. J., 1982, Surface antigens of melanocytes and melanomas. Markers of melanocyte differentiation and melanoma subsets.Journal of Experimental Medicine,156, 1755–1766.
Kreider, J. W., Rosenthal, M., andLengle, N., 1973, Cyclic adenosine 3′, 5′ monophosphate in the control of melanoma cell replication and differentiation.Journal of the National Cancer Institute,50, 555–558.
Merril, C. R., Goldman, D., Sedman, S. A., andEbert, H., 1981, Ultrasensitive stain for proteins in polyacrylamide gels shows regional variation in cerebrospinal fluid proteins.Science,211, 1437–1438.
Ormerod, E. J., Everett, C. A., andHart, I. R., 1986, Enhanced experimental metastatic capacity of a human tumor line following treatment with 5-azacytidine.Cancer Research,46, 884–890.
Ormerod, E. J., Everett, C. A., Finch, M., andHart, I. R. 1986, DNA methylation levels in human and murine melanoma cell lines of varying metastatic potential.Cancer Research,46, 4342–4345.
Ormerod, E. J., andHart, I. R., 1989, Different growth responses to agents which elevate cAMP in human melanoma cell lines of high and low experimental metastatic capacity.Clinical and Experimental Metastasis,7, 85–95.
Taniguchi, S., Kawano, T., Kakunaga, T., andBaba, T., 1986, Differences in expression of a variant actin between low and high metastatic B16 melanoma.Journal of Biological Chemistry,261, 6100–6106.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Easty, D., Hart, I.R., Patel, K. et al. Changes in protein expression during melanoma differentiation determined by computer analysis of 2-D gels. Clin Exp Metast 9, 221–230 (1991). https://doi.org/10.1007/BF01753726
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01753726